Letter From The Editor: Important Information On PharmAsia News
This article was originally published in PharmAsia News
PharmAsia News will cease publication as a stand-alone product at the end of June/early July. However, the on-the-ground team of journalists who produce PAN will all continue to provide the same in-depth insight, news, and analysis as previously, and this content will be made available through Informa’s updated Scrip platform. All PAN subscribers will receive Scrip from early July, and Asia-Pacific regulatory content will be available through the expanded Pink Sheet and its new platform.